KR100515922B1 - Process for preparing of dibenzothiepin - Google Patents

Process for preparing of dibenzothiepin Download PDF

Info

Publication number
KR100515922B1
KR100515922B1 KR1020040101502A KR20040101502A KR100515922B1 KR 100515922 B1 KR100515922 B1 KR 100515922B1 KR 1020040101502 A KR1020040101502 A KR 1020040101502A KR 20040101502 A KR20040101502 A KR 20040101502A KR 100515922 B1 KR100515922 B1 KR 100515922B1
Authority
KR
South Korea
Prior art keywords
formula
compound
iodine
reaction
peroxide
Prior art date
Application number
KR1020040101502A
Other languages
Korean (ko)
Inventor
조동옥
강신욱
Original Assignee
(주)유케이케미팜
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)유케이케미팜 filed Critical (주)유케이케미팜
Priority to KR1020040101502A priority Critical patent/KR100515922B1/en
Application granted granted Critical
Publication of KR100515922B1 publication Critical patent/KR100515922B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D337/00Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
    • C07D337/02Seven-membered rings
    • C07D337/06Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D337/10Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D337/14[b,f]-condensed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J27/00Catalysts comprising the elements or compounds of halogens, sulfur, selenium, tellurium, phosphorus or nitrogen; Catalysts comprising carbon compounds
    • B01J27/06Halogens; Compounds thereof
    • B01J27/08Halides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)

Abstract

본 발명은 하기 화학식 I의 디벤조티에핀 화합물을 제조하는 방법에 관한 것으로서, 상세하게는 a) 하기 화학식(II)의 프로피오페논 유도체와 알킬렌디올 또는 모노알코올로부터 선택되는 알코올로 이루어진 반응 혼합물에 요오드(I2)촉매와 요오드클로라이드(ICl) 또는 요오드브로마이드(IBr)을 가한 후, 상기 반응 혼합물에 과산화물을 가하여 화학식 III의 디카르복실산 에스테르 화합물을 제조하는 단계; b) 화학식 III의 디카르복실산 에스테르 화합물을 산 축합제 존재 하에 화학식 I의 디벤조티에핀 화합물로 변환시키는 단계; 로 이루어지는 것을 특징으로 한다.The present invention relates to a process for preparing a dibenzothiepyne compound of formula (I), specifically a) a reaction mixture comprising a propiophenone derivative of formula (II) and an alcohol selected from alkylenediol or monoalcohol Adding iodine (I 2 ) catalyst with iodine chloride (ICl) or iodine bromide (IBr), and then adding a peroxide to the reaction mixture to prepare a dicarboxylic acid ester compound of formula III; b) converting the dicarboxylic acid ester compound of formula III to a dibenzothiefine compound of formula I in the presence of an acid condensing agent; Characterized in that consists of.

Description

디벤조티에핀 유도체의 개선된 제조방법{Process for preparing of dibenzothiepin}Process for preparing of dibenzothiepin

본 발명은 하기 화학식 I의 디벤조티에핀 화합물을 제조하는 방법에 관한 것으로서, 상세하게는 a) 하기 화학식(II)의 프로피오페논 유도체와 알킬렌디올 또는 모노알코올로부터 선택되는 알코올로 이루어진 반응 혼합물에 요오드(I2) 촉매와 요오드클로라이드(ICl) 또는 요오드브로마이드(IBr)를 가한 후, 상기 반응 혼합물에 과산화물을 가하여 화학식 III의 디카르복실산 에스테르 화합물을 제조하는 단계; b) 화학식 III의 디카르복실산 에스테르 화합물을 산 축합제 존재 하에 화학식 I의 디벤조티에핀 화합물로 변환시키는 단계; 로 이루어지는 것을 특징으로 한다.The present invention relates to a process for preparing a dibenzothiepyne compound of formula (I), specifically a) a reaction mixture comprising a propiophenone derivative of formula (II) and an alcohol selected from alkylenediol or monoalcohol Adding an iodine (I 2 ) catalyst and iodine chloride (ICl) or iodine bromide (IBr), and then adding a peroxide to the reaction mixture to prepare a dicarboxylic acid ester compound of formula III; b) converting the dicarboxylic acid ester compound of formula III to a dibenzothiefine compound of formula I in the presence of an acid condensing agent; Characterized in that consists of.

[상기 화학식에서 R1은 C1-C6의 직쇄 또는 측쇄의 알킬기, 페닐기 또는 벤질기이고, 상기 페닐기와 벤질기에 포함된 페닐기는 C1-C6의 직쇄 또는 측쇄의 알킬, 니트로, 할로겐, 메톡시로 치환될 수 있으며, R2는 C1-C6의 직쇄 또는 측쇄의 알킬기이다.][Wherein R 1 is a C 1 -C 6 linear or branched alkyl, phenyl or benzyl group, and the phenyl group contained in the phenyl group and the benzyl group is C 1 -C 6 linear or branched alkyl, nitro, halogen, May be substituted with methoxy, and R 2 is a C 1 -C 6 straight or branched alkyl group.]

하기 화학식 I의 디벤조티에핀 화합물 즉 2-(10,11-디히드로-10-옥소디벤조[b,f]티에핀-2-일)프로피온산은 높은 항염작용 및 높은 진통작용을 갖는 유용한 화합물로서 특히 거의 부작용이 없는 실제적으로 유용한 항염제로 알려져 있다.Dibenzothiefine compounds of formula (I), i.e. 2- (10,11-dihydro-10-oxodibenzo [b, f] thipin-2-yl) propionic acid, are useful compounds with high anti-inflammatory and high analgesic activity In particular, it is known as a practically useful anti-inflammatory agent with little side effects.

화학식 I의 디벤조티에핀 화합물에 대한 제조방법으로 일본공개특허공보 소58-113168호에는 반응식 1에 도시된 바와 같이 브로모케톤 유도체로부터 토실화 아세탈 화합물을 제조한 후 전위반응에 의하여 디카르복실산 화합물을 제조한 후 고리화 반응에 의하여 화학식 I의 디벤조티에핀 화합물을 제조하는 방법이 공지되어 있다. As a method for preparing a dibenzothione compound of Formula (I), Japanese Patent Application Laid-Open No. 58-113168 discloses a dicarboxyl by preparing a tosylated acetal compound from a bromoketone derivative as shown in Scheme 1. It is known to prepare dibenzothiepyne compounds of formula (I) by the preparation of acid compounds followed by cyclization reactions.

[반응식 1]Scheme 1

또한 상기의 제조방법과 유사한 방법으로서 대한민국특허공고공보 1992-6613호에는 하기의 반응식 2에 도시된 단계를 거쳐 화학식 I의 디벤조티에핀 화합물을 제조하는 방법이 공지되어 있다.In addition, Korean Patent Publication No. 1992-6613 discloses a method for preparing a dibenzothione compound of Formula (I) through the steps shown in Scheme 2 below.

[반응식 2]Scheme 2

상기의 공지 방법들은 할로아세탈 또는 토실화 아세탈을 ZnCl2 또는 염기조건 하에서 전위반응하여 디카르복실산을 제조하는 반응을 거치는 제조방법으로서 ZnCl2 등 금속염 루이스산을 사용하는 경우 루이스산이 고가일 뿐 만 아니라 ZnCl2 등 인체에 해로운 금속염을 제거해야 하는 문제가 있으며, 염기 조건에서의 전위 반응은 100℃ 이상의 고온에서 장시간 가열해야 하기 때문에 생산성이 떨어질 뿐만 아니라 부반응으로 인한 수율의 저하 등의 문제가 있다.The above known methods are a method of producing a dicarboxylic acid by inverting a halo acetal or tosylated acetal under ZnCl 2 or basic conditions, and when a metal salt Lewis acid such as ZnCl 2 is used, Lewis acid is only expensive. In addition, there is a problem of removing metal salts harmful to the human body, such as ZnCl 2 , and the potential reaction under basic conditions requires heating for a long time at a high temperature of 100 ° C. or higher, thereby lowering productivity and lowering yields due to side reactions.

이에 본 발명의 목적은 경제적이고 온화한 반응조건으로 디벤조티에핀 화합물을 제조하는 방법을 제공하는 것이며, 또 다른 목적은 5-프로피오닐-2-페닐티오페닐아세테이트로부터 단일 반응기에서 높은 수율로 5-(1-카르복시에틸)-2-페닐-티오아세테이트 유도체를 제조하는 방법을 제공하는 것이다. Accordingly, an object of the present invention is to provide a method for preparing a dibenzothiepine compound under economic and mild reaction conditions, and another object is a 5-yield with high yield in a single reactor from 5-propionyl-2-phenylthiophenylacetate. It is to provide a method for producing a (1-carboxyethyl) -2-phenyl-thioacetate derivative.

본 발명은 하기 화학식 I의 디벤조티에핀 화합물을 제조하는 방법에 관한 것으로서, 상세하게는 a) 하기 화학식(II)의 프로피오페논 유도체와 알킬렌디올 또는 모노알코올로부터 선택되는 알코올로 이루어진 반응 혼합물에 요오드(I2) 촉매와 요오드클로라이드(ICl) 또는 요오드브로마이드(IBr)를 가한 후, 상기 반응 혼합물에 과산화물을 가하여 화학식 III의 디카르복실산 에스테르 화합물을 제조하는 단계; b) 화학식 III의 디카르복실산 에스테르 화합물을 산 축합제 존재 하에 화학식 I의 디벤조티에핀 화합물로 변환시키는 단계; 로 이루어지는 것을 특징으로 한다.The present invention relates to a process for preparing a dibenzothiepyne compound of formula (I), specifically a) a reaction mixture comprising a propiophenone derivative of formula (II) and an alcohol selected from alkylenediol or monoalcohol Adding an iodine (I 2 ) catalyst and iodine chloride (ICl) or iodine bromide (IBr), and then adding a peroxide to the reaction mixture to prepare a dicarboxylic acid ester compound of formula III; b) converting the dicarboxylic acid ester compound of formula III to a dibenzothiefine compound of formula I in the presence of an acid condensing agent; Characterized in that consists of.

[상기 화학식에서 R1은 C1-C6의 직쇄 또는 측쇄의 알킬기, 페닐기 또는 벤질기이고, 상기 페닐기와 벤질기에 포함된 페닐기는 C1-C6의 직쇄 또는 측쇄의 알킬, 니트로, 할로겐, 메톡시로 치환될 수 있으며, R2는 C1-C6의 직쇄 또는 측쇄의 알킬기이다.][Wherein R 1 is a C 1 -C 6 linear or branched alkyl, phenyl or benzyl group, and the phenyl group contained in the phenyl group and the benzyl group is C 1 -C 6 linear or branched alkyl, nitro, halogen, May be substituted with methoxy, and R 2 is a C 1 -C 6 straight or branched alkyl group.]

이하 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.

본 발명에 따른 화학식 I의 디벤조티에핀 화합물을 제조하는 방법은 하기의 반응식 3에 도시된 바와 같이 출발물질인 화학식 II의 5-프로피오닐-2-페닐티오페닐아세테이트로부터 화학식 III의 5-(1-카르복시에틸)-2-페닐-티오아세테이트 유도체를 제조하는 단계와 상기 첫 번째 반응단계로부터 제조된 화학식 III의 5-(1-카르복시에틸)-2-페닐-티오아세테이트 유도체를 축합반응에 의하여 고리화하여 목적화합물인 화학식 I의 디벤조티에핀 화합물을 제조하는 단계로 구성된다.The process for preparing the dibenzothiefine compound of formula (I) according to the present invention is carried out from 5-propionyl-2-phenylthiophenylacetate of formula (II) as starting material, as shown in Scheme 3 below. Preparing a 1-carboxyethyl) -2-phenyl-thioacetate derivative and a 5- (1-carboxyethyl) -2-phenyl-thioacetate derivative of formula III prepared from the first reaction step by condensation reaction. Cyclization to prepare a dibenzothiepyne compound of formula (I) as a target compound.

[반응식 3]Scheme 3

첫 번째 단계는 화학식 II의 5-프로피오닐-2-페닐티오페닐아세테이트 유도체와 알킬렌디올 또는 모노알코올로부터 선택되는 알코올로 이루어진 반응혼합물에 요오드(I2) 촉매와 요오드클로라이드(ICl) 또는 요오드브로마이드(IBr)를 가한 후, 상기 반응 혼합물에 과산화물을 가하여 화학식 III의 디카르복실산 에스테르 화합물을 제조하는 단계이다.The first step is an iodine (I 2 ) catalyst and iodine chloride (ICl) or iodine bromide in a reaction mixture consisting of a 5-propionyl-2-phenylthiophenylacetate derivative of formula II and an alcohol selected from alkylenediol or monoalcohol. After adding (IBr), a peroxide is added to the reaction mixture to prepare a dicarboxylic acid ester compound of formula III.

요오드는 촉매량으로서 사용되는 것이 바람직하며, 요오드클로라이드 또는 요오드브로마이드는 화학식 II의 5-프로피오닐-2-페닐티오페닐아세테이트 유도체 1몰당 0.5 내지 1몰을 사용하는 것이 바람직하다.Iodine is preferably used as the catalytic amount, and iodine chloride or iodine bromide is preferably used at 0.5 to 1 mole per mole of 5-propionyl-2-phenylthiophenylacetate derivative of formula II.

상기 단계에서 가해지는 과산화물은 C1-C5알킬 카르복실산의 과산화물, 퍼벤조산, m-클로로퍼벤조산 또는 과산화수소가 바람직하며, 특히 퍼아세트산 또는 m-클로로퍼벤조산이 더욱 바람직하며, 퍼아세트산의 사용함량은 30 내지 40%이다.The peroxide added in this step is preferably a peroxide of C 1 -C 5 alkyl carboxylic acid, perbenzoic acid, m-chloroperbenzoic acid or hydrogen peroxide, more particularly peracetic acid or m-chloroperbenzoic acid, The content used is 30 to 40%.

알킬렌디올은 1,2-에탄디올, 1,2-프로판디올, 1,3-프로판디올, 1,2-부탄디올, 1,3-부탄디올, 2,3-부탄디올이 바람직하며, 모노알코올은 메탄올, 에탄올, n-프로판올, i-프로판올이 바람직하며, 알킬렌디올의 경우 고리화 아세탈을 형성하여 전위반응 시 화학식 III의 5-(1-카르복시에틸)-2-페닐-티오아세테이트 유도체의 카르복실산 에스테르가 치환된 벤질위치의 입체 선택성이 뛰어날 뿐 만 아니라 부반응이 적어 특히 바람직하며, 특히 1,2-에탄디올, 1,2-프로판디올 또는 1,3-프로판디올이 가장 바람직하다. The alkylene diol is preferably 1,2-ethanediol, 1,2-propanediol, 1,3-propanediol, 1,2-butanediol, 1,3-butanediol, 2,3-butanediol, and monoalcohol is methanol , Ethanol, n-propanol, i-propanol are preferred, and in the case of alkylenediol, cyclyl of 5- (1-carboxyethyl) -2-phenyl-thioacetate derivative of formula III during the reaction by forming cyclized acetal Not only is it excellent in the stereoselectivity of the benzyl position substituted with acid esters, but also there are few side reactions, and especially a 1, 2- ethanediol, a 1, 2- propanediol, or 1, 3- propanediol is the most preferable.

한편 상기의 전위반응 단계에서 용매 내에 존재하는 수분의 영향으로 요오드착물의 분해를 극복하기 위하여 과산화물과 함께 C1-C5알킬 카르복실산의 금속염을 완충용액으로 가하는 것이 바람직하며, 상기의 카르복실산의 금속염을 가하면 반응조건이 더욱 온화해질 뿐 만 아니라 부반응이 없이 반응이 진행되는 장점이 있으며, 특히 금속완충용액으로 사용되기에 바람직한 물질은 소듐 아세테이트, 포타슘 아세테이트이다.On the other hand, in order to overcome the decomposition of the iodine complex under the influence of the water present in the solvent in the above reaction step, it is preferable to add a metal salt of C 1 -C 5 alkyl carboxylic acid with a peroxide as a buffer, the carboxyl The addition of the metal salt of acid not only makes the reaction conditions more gentle, but also has the advantage that the reaction proceeds without side reactions. Particularly, preferable materials for use as a metal buffer solution are sodium acetate and potassium acetate.

상기 전위반응에서 사용되는 용매는 메틸렌클로라이드, 사염화탄소, 디에틸에테르, 테트라하이드로퓨란, 벤젠, 톨루엔 등 반응에 참여하지 않는 용매 중에 수행될 수 있으며, 또한 반응물로서 사용되는 알코올을 용매로서 사용하여 수행할 수 있으며, 반응은 -10 내지 70℃의 온도에서 수행되며, 특히 바람직하기로는 0 내지 30℃의 반응온도가 바람직하며, 반응시간은 0.5 내지 4시간동안 수행되며, 1시간 이내에 대부분의 반응이 완료된다.The solvent used in the potential reaction can be carried out in a solvent that does not participate in the reaction, such as methylene chloride, carbon tetrachloride, diethyl ether, tetrahydrofuran, benzene, toluene, and also can be carried out using an alcohol used as a reactant as a solvent. The reaction is carried out at a temperature of -10 to 70 ℃, particularly preferably a reaction temperature of 0 to 30 ℃, the reaction time is carried out for 0.5 to 4 hours, most of the reaction is completed within 1 hour do.

본 발명에 따른 화학식 I의 디벤조티에핀 화합물을 제조하는 방법의 전위반응 단계는 하기 반응식 4에 도시된 바와 같이 과산화물 알파-요오드아세탈 착물 중간체(IV)를 형성하여 전위반응에 의하여 화학식 III의 5-(1-카르복시에틸)-2-페닐-티오아세테이트 유도체가 제조되는 과정을 거친다.The dislocation reaction step of the method for preparing the dibenzothiepyne compound of formula I according to the present invention is carried out by dislocation reaction to form a peroxide alpha-iodine acetal complex intermediate (IV) as shown in Scheme 4 below. -(1-carboxyethyl) -2-phenyl-thioacetate derivative is prepared.

[반응식 4]Scheme 4

[상기 반응식에서 R1 및 R2는 앞서 기재한 바와 동일하며, R3는 C1-C5알킬기 또는 R3가 서로 -(CH2)n-으로 결합된 것이다.][Wherein R 1 and R 2 are the same as described above, and R 3 is a C1-C5 alkyl group or R 3 bonded to each other with-(CH 2 ) n- .]

알파-요오도아세탈 착물 중간체(IV)는 전위반응 후 화학식 III의 5-(1-카르복시에틸)-2-페닐-티오아세테이트 유도체 제조 중에 다시 요오드브로마이드(또는 요오드클로라이드)가 생성되어 다시 알파-요오드아세탈 착물 중간체(IV)를 형성에 관여하는 순환식 반응이다. The alpha-iodoacetal complex intermediate (IV) is subjected to an iodine bromide (or iodine chloride) again during the preparation of the 5- (1-carboxyethyl) -2-phenyl-thioacetate derivative of Formula III after the rearrangement, and then to the alpha-iodine It is a cyclic reaction that is involved in the formation of the acetal complex intermediate (IV).

본 발명에 따른 제조방법은 요오드 촉매와 요오드클로라이드(ICl) 또는 요오드브로마이드(IBr)와 과산화물 및 완충용액으로 카르복실산 금속염을 함께 가하여 반응시키는 것도 가능하며, 과산화물 및 완충용액으로 카르복실산 금속염을 가한 후 요오드클로라이드(ICl) 또는 요오드브로마이드(IBr)를 가하여 반응시키는 것도 가능하다.According to the present invention, the iodine catalyst and iodine chloride (ICl) or iodine bromide (IBr) may be reacted by adding a carboxylic acid metal salt together with a peroxide and a buffer solution, and the carboxylic acid metal salt may be reacted with a peroxide and a buffer solution. After addition, it is also possible to react by adding iodine chloride (ICl) or iodine bromide (IBr).

이는 알파-요오도아세탈 착물 중간체가 아세탈화와 알파요오드화와 함께 동시에 생성됨을 의미한다.This means that alpha-iodoacetal complex intermediates are produced simultaneously with acetalization and alpha iodide.

상기 첫 번째 반응단계로부터 제조된 화학식 III의 5-(1-카르복시에틸)-2-페닐-티오아세테이트 유도체를 축합반응에 의하여 고리화하여 목적화합물인 화학식 I의 디벤조티에핀 화합물을 제조하는 단계는 종래의 고리화 반응을 진행하는 단계와 유사한 조건으로 진행된다.Preparing a dibenzothiene compound of formula (I) as a target compound by cyclization of 5- (1-carboxyethyl) -2-phenyl-thioacetate derivative of formula (III) prepared from the first reaction step by condensation; Is carried out under similar conditions to the step of proceeding the conventional cyclization reaction.

상세하게는 화학식 III의 디카르복실산 에스테르를 가수분해를 통해 디카르복실산을 제조한 후 디카르복실산을 축합제의 존재 하에 화학식 I의 디벤조티에핀 화합물을 제조하며, 축합반응과 가수반응의 단계의 순서가 바꾸어 진행될 수 있다. 가수분해는 통상의 방법, 예를 들어, 염기성 수용액 또는 산성 수용액 중에서 디카르복실산 에스테르를 가열하여 수행하며, 축합제는 디카르복실산 1중량에 대해 1-10배 중량으로 사용됨이 바람직하다. 축합제의 예로서, 황산, 폴리인산 또는 폴리인산 에스테르가 바람직하며, 축합반응은 실온 내지 120℃의 온도 범위에서 10분 내지 10시간동안 수행된다. 반응완료 후, 반응 혼합물의 산성의 수성 혼합물에 유기용매를 가하여 반응 생성물을 추출하고, 유기용매를 증류하여, 제거하고 반응 생성물을 수득한다. 반응 생성물을 재결정법 등의 방법으로 정제할 수 있다.Specifically, the dicarboxylic acid is prepared by hydrolysis of the dicarboxylic acid ester of formula III, and then the dibenzoic acid compound of formula I is prepared in the presence of a condensing agent. The order of the steps of the reaction can be reversed. Hydrolysis is carried out by heating the dicarboxylic acid ester in a conventional method, for example, in an aqueous basic solution or an acidic aqueous solution, and the condensing agent is preferably used 1 to 10 times by weight based on 1 weight of dicarboxylic acid. As an example of the condensing agent, sulfuric acid, polyphosphoric acid or polyphosphoric acid ester is preferred, and the condensation reaction is carried out for 10 minutes to 10 hours in the temperature range of room temperature to 120 ° C. After completion of the reaction, an organic solvent is added to the acidic aqueous mixture of the reaction mixture to extract the reaction product, the organic solvent is distilled off, and the reaction product is obtained. The reaction product can be purified by a method such as recrystallization.

고리화 반응에 의한 화학식 I의 디벤조티에핀 화합물의 제조단계는 종래의 디벤조티에핀 화합물 고리화 반응에 공지되어 있으므로 상세한 설명은 생략한다.The step of preparing the dibenzothiefine compound of formula (I) by cyclization reaction is known in the conventional dibenzothiefine compound cyclization reaction, and thus detailed description thereof is omitted.

화학식 II 화합물로부터 화학식 III 화합물을 제조 수율은 91% 이상의 높은 수율로 수득될 뿐 만 아니라 반응조건이 온화하여 부반응이 적어서 수득된 화학식 III 화합물을 분리하지 않고 화학식 1의 디벤조티에핀 화합물을 직접 제조하여도 고리화 반응의 수율이 높을 뿐만 아니라 최종 생성물의 분리가 용이한 장점이 있다.Preparation of the compound of formula III from the compound of formula II The yield is not only obtained in a high yield of 91% or more, but also the dibenzothiepine compound of formula 1 is prepared directly without separating the compound of formula III obtained due to mild reaction conditions and low side reactions. Even if the yield of the cyclization reaction is not only high, there is an advantage that the separation of the final product is easy.

하기 실시 예로 본 발명을 더 상세히 설명한다. 또한 하기의 실시 예가 본 발명의 사상을 제한하는 것은 아니다.The following examples illustrate the invention in more detail. In addition, the following examples do not limit the spirit of the present invention.

[실시예 1]Example 1

메틸 5-(1-프로폭시카보닐에틸)-2-페닐-티오아세테이트의 제조Preparation of Methyl 5- (1-propoxycarbonylethyl) -2-phenyl-thioacetate

질소 분위기 하에 메틸 5-프로피오닐-2-페닐티오페닐아세테이트 50.0g을 반응기에 넣고 1,3-프로판디올 400mL를 가한 후, 반응 혼합물을 0℃로 냉각한 후 요오드(I2) 촉매량(5mg)과 요오드클로라이드(ICl) 25.9g을 서서히 가한다.50.0 g of methyl 5-propionyl-2-phenylthiophenyl acetate was added to the reactor under a nitrogen atmosphere, and 400 mL of 1,3-propanediol was added.The reaction mixture was cooled to 0 ° C., and then the amount of iodine (I 2 ) catalyst (5 mg) was added. And 25.9 g of iodine chloride (ICl) are added slowly.

반응액을 30분간 교반한 후 실온에서 소듐 아세테이트 0.75g과 38 내지 40% 의 퍼아세트산 45mL 혼합액을 서서히 가한 후 실온에서 2시간 교반한다. After stirring the reaction solution for 30 minutes, 0.75 g of sodium acetate and a mixture of 38 to 40% peracetic acid 45 mL were slowly added at room temperature, followed by stirring at room temperature for 2 hours.

반응용매를 감압 하에 농축한 후 반응생성물에 디에틸에테르 500mL을 가한 후 물 300 mL을 가하여 연속해서 3회 세척한다. 유기층을 포화탄산수소나트륨용액 400mL를 가하여 세척한 후 감압 농축하여 표제 화합물 49.8g(91.0%)을 수득하였다.After concentrating the reaction solvent under reduced pressure, 500 mL of diethyl ether was added to the reaction product, followed by 300 mL of water, followed by three successive washings. The organic layer was washed with 400 mL of saturated sodium hydrogen carbonate solution and concentrated under reduced pressure to give 49.8 g (91.0%) of the title compound.

[실시예 2] Example 2

메틸 5-(1-에톡시카보닐에틸)-2-페닐-티오아세테이트의 제조Preparation of Methyl 5- (1-ethoxycarbonylethyl) -2-phenyl-thioacetate

질소 분위기 하에 메틸 5-프로피오닐-2-페닐티오페닐아세테이트 50.0g을 반응기에 넣고 1,2-에탄디올 400mL를 가한 후, 반응 혼합물을 0℃로 냉각한 후 요오드(I2) 촉매량(5mg)과 요오드클로라이드(ICl) 25.9g을 서서히 가한다.50.0 g of methyl 5-propionyl-2-phenylthiophenyl acetate was added to the reactor under a nitrogen atmosphere, and 400 mL of 1,2-ethanediol was added thereto.The reaction mixture was cooled to 0 ° C., and the amount of iodine (I 2 ) catalyst (5 mg) was added. And 25.9 g of iodine chloride (ICl) are added slowly.

반응액을 30분간 교반한 후 실온에서 소듐 아세테이트 0.75g과 38 내지 40% 의 퍼아세트산 45mL 혼합액을 서서히 가한 후 실온에서 2시간 교반한다. After stirring the reaction solution for 30 minutes, 0.75 g of sodium acetate and a mixture of 38 to 40% peracetic acid 45 mL were slowly added at room temperature, followed by stirring at room temperature for 2 hours.

반응용매를 감압 하에 농축한 후 반응생성물에 디에틸에테르 500mL을 가한 후 물 300 mL를 가하여 연속해서 3회 세척한다. 유기층을 포화탄산수소나트륨용액 400mL를 가하여 세척한 후 감압 농축하여 표제 화합물49.0g(89.6%)을 수득하였다.The reaction solvent was concentrated under reduced pressure, 500 mL of diethyl ether was added to the reaction product, followed by 300 mL of water, followed by three successive washings. The organic layer was washed with 400 mL of saturated sodium hydrogen carbonate solution, and then concentrated under reduced pressure to obtain 49.0 g (89.6%) of the title compound.

[실시예 3]Example 3

메틸 5-(1-프로폭시카보닐에틸)-2-페닐-티오아세테이트의 제조Preparation of Methyl 5- (1-propoxycarbonylethyl) -2-phenyl-thioacetate

질소 분위기 하에 메틸 5-프로피오닐-2-페닐티오페닐아세테이트 50.0g을 반응기에 넣고 1,3-프로판디올 400mL를 가한 후, 반응 혼합물을 0℃로 냉각한 후 요오드(I2) 촉매량(5mg)과 요오드 모노클로라이드(ICl) 25.9g을 가하면서 동시에 소듐 아세테이트 0.75g과 38 내지 40% 의 퍼아세트산 45mL 혼합액을 가한 후 실온에서 2시간 교반한다. 반응용매를 감압 하에 농축한 후 반응생성물에 디에틸에테르 500mL을 가한 후 물 300mL를 가하여 연속해서 3회 세척한다. 유기층을 포화탄산수소나트륨용액 400mL를 가하여 세척한 후 감압 농축하여 표제 화합물48.0g(87.8%)을 수득하였다.50.0 g of methyl 5-propionyl-2-phenylthiophenyl acetate was added to the reactor under a nitrogen atmosphere, and 400 mL of 1,3-propanediol was added.The reaction mixture was cooled to 0 ° C., and then the amount of iodine (I 2 ) catalyst (5 mg) was added. 25.9 g of iodine monochloride (ICl) and 0.75 g of sodium acetate and 45 to 40% peracetic acid mixture were added thereto, followed by stirring at room temperature for 2 hours. The reaction solvent was concentrated under reduced pressure, 500 mL of diethyl ether was added to the reaction product, followed by 300 mL of water, followed by three successive washings. The organic layer was washed with 400 mL of saturated sodium hydrogen carbonate solution and concentrated under reduced pressure to give 48.0 g (87.8%) of the title compound.

[실시예 4]Example 4

5-(1-카르복시에틸)-2-페닐티오페닐-아세트산의 제조Preparation of 5- (1-carboxyethyl) -2-phenylthiophenyl-acetic acid

실시예 1에서 수득한 메틸 5-(1-프로폭시카보닐에틸)-2-페닐-티오아세테이트 30g을 메탄올 150mL에 녹인 후 0℃로 냉각한 후, NaOH 9g을 정제수 30mL에 녹인 용액을 서서히 가한 후 30분 동안 교반한다. 반응물을 실온으로 승온한 후 4시간동안 교반한고, 반응 혼합물의 용매을 감압 농축하여 메탄올을 제거한 후 물 200mL을 가한다. 수성층의 생성 혼합물을 디에틸에테르 150mL로 세척하고, 수성층을 5℃로 냉각한 후 3N-HCl로 pH을 1.0으로 조정한 후, 메틸렌클로라이드 200mL로 3회 반복 추출한 후 유기층을 무수 황산나트륨으로 건조, 여과하여, 감압 하에 용매을 제거하여 표제 화합물 24.4 g(88.4%)을 얻었다.30 g of methyl 5- (1-propoxycarbonylethyl) -2-phenyl-thioacetate obtained in Example 1 was dissolved in 150 mL of methanol, cooled to 0 ° C., and a solution of 9 g of NaOH in 30 mL of purified water was slowly added thereto. After stirring for 30 minutes. The reaction was warmed to room temperature and stirred for 4 hours. The solvent of the reaction mixture was concentrated under reduced pressure to remove methanol, and 200 mL of water was added thereto. The resulting mixture of the aqueous layer was washed with 150 mL of diethyl ether, the aqueous layer was cooled to 5 ° C., the pH was adjusted to 1.0 with 3N-HCl, extracted three times with 200 mL of methylene chloride, and the organic layer was dried over anhydrous sodium sulfate and filtered. The solvent was removed under reduced pressure to give 24.4 g (88.4%) of the title compound.

NMR(CDCl3) δ:3.82(1H), 3.48(2H), 1.46(3H), 7.22-7.6(8H)NMR (CDCl 3 ) δ: 3.82 (1H), 3.48 (2H), 1.46 (3H), 7.22-7.6 (8H)

[실시예 5]Example 5

5-(1-카르복시에틸)-2-페닐티오페닐-아세트산의 제조Preparation of 5- (1-carboxyethyl) -2-phenylthiophenyl-acetic acid

실시예 2에서 수득한 메틸 5-(1-에톡시카보닐에틸)-2-페닐-티오아세테이트 30g을 메탄올 150mL에 녹인 후 0℃로 냉각한 후, NaOH 9g을 정제수 30mL에 녹인 용액을 서서히 가한 후 30분 동안 교반한다. 반응물을 실온으로 승온한 후 4시간동안 교반한고, 반응 혼합물의 용매을 감압 농축하여 메탄올을 제거한 후 물 200mL를 가한다. 수성층의 생성 혼합물을 디에틸에테르 150mL로 세척하고, 수성층을 5℃로 냉각한 후 3N-HCl로 pH를 1.0으로 조정한 후, 메틸렌클로라이드 200mL로 3회 반복 추출한 후 유기층을 무수 황산나트륨으로 건조, 여과하여, 감압 하에 용매을 제거하여 표제 화합물 24.9g(90.1%)을 얻었다.30 g of methyl 5- (1-ethoxycarbonylethyl) -2-phenyl-thioacetate obtained in Example 2 was dissolved in 150 mL of methanol, cooled to 0 ° C., and a solution of 9 g of NaOH in 30 mL of purified water was slowly added thereto. After stirring for 30 minutes. The reaction was warmed to room temperature, stirred for 4 hours, the solvent of the reaction mixture was concentrated under reduced pressure to remove methanol, and 200 mL of water was added thereto. The resulting mixture of the aqueous layer was washed with 150 mL of diethyl ether, the aqueous layer was cooled to 5 ° C., the pH was adjusted to 1.0 with 3N-HCl, extracted three times with 200 mL of methylene chloride, and the organic layer was dried over anhydrous sodium sulfate and filtered. The solvent was removed under reduced pressure to give 24.9 g (90.1%) of the title compound.

NMR(CDCl3) δ:3.82(1H), 3.48(2H), 1.46(3H), 7.22-7.6(8H)NMR (CDCl 3 ) δ: 3.82 (1H), 3.48 (2H), 1.46 (3H), 7.22-7.6 (8H)

[실시예 5]Example 5

2-(10,11-디히드로-10-옥소디벤조[b,f]티에핀-2-일)프로피온산의 제조Preparation of 2- (10,11-dihydro-10-oxodibenzo [b, f] thiin-2-yl) propionic acid

상기 실시예 4에서 얻은 5-(1-카르복시에틸)-2-페닐티오페닐-아세트산 20g과 PPA(폴리인산) 100g을 혼합한 후, 혼합물을 서서히 80℃로 가열 승온하여, 반응물의 온도를 유지 하면서 4시간 교반한 후 반응 혼합물을 얼음물 300mL 속에 가한 후 에틸아세테이트 300mL로 4회 반복 추출한다. 유기층을 물 400mL로 세척한 후 무수황산나트륨으로 건조, 여과한 후, 용매를 감압 농축 하여 표제화합물 15.3g(81.3%)을 얻었다.After mixing 20 g of 5- (1-carboxyethyl) -2-phenylthiophenyl-acetic acid obtained in Example 4 and 100 g of PPA (polyphosphoric acid), the mixture was gradually heated to 80 ° C. to maintain the temperature of the reactant. After stirring for 4 hours, the reaction mixture was added to 300 mL of ice water, and extracted four times with 300 mL of ethyl acetate. The organic layer was washed with 400 mL of water, dried over anhydrous sodium sulfate, filtered, and the solvent was concentrated under reduced pressure to obtain 15.3 g (81.3%) of the title compound.

NMR(CDCl3)δ: 1.46(3H), 3.80-3.84(3H), 6.6-7.81(7H)NMR (CDCl 3 ) δ: 1.46 (3H), 3.80-3.84 (3H), 6.6-7.81 (7H)

[비교예 1]Comparative Example 1

메틸 5-(2-브로모프로피오닐)-2-페닐-티오페닐아세테이트의 제조Preparation of Methyl 5- (2-bromopropionyl) -2-phenyl-thiophenylacetate

질소 분위기 하에 5-프로피오닐-2-페닐티오페닐아세테이트 50.0g(0.159mol)을 반응기에 넣고 메틸렌클로라이드 340.0mL를 가하여 녹인 후, 반응액을 0 내지 5℃로 냉각한 후 브롬 8.15mL을 메틸렌클로라이드 50.0mL로 희석하여 반응액에 서서히 적가하고, 반응액의 온도를 유지하면서 1.5시간 교반한다.50.0 g (0.159 mol) of 5-propionyl-2-phenylthiophenyl acetate was added to the reactor under a nitrogen atmosphere, and 340.0 mL of methylene chloride was added thereto to dissolve. The reaction solution was cooled to 0 to 5 ° C, and bromine 8.15 mL was dissolved in methylene chloride. Dilute to 50.0 mL, and slowly add dropwise to the reaction solution, and stir for 1.5 hours while maintaining the temperature of the reaction solution.

반응액에 물 200mL를 가하여 30분간 교반한 후 유기층을 분리하고, 분리한 유기층을 다시 물 200mL로 2회 반복 세척한 후 감압 농축하여 유기 용매를 제거한 후, 메탄올 110mL를 가하고 40℃에서 10분간 교반한다.200 mL of water was added to the reaction solution, the mixture was stirred for 30 minutes, and the organic layer was separated. The organic layer was separated and washed twice with 200 mL of water, and then concentrated under reduced pressure to remove the organic solvent. do.

생성물 용액을 0 내지 5℃ 온도에서 5시간 교반하여 결정을 형성 시키고, 생성된 결정을 여과한다. 여과물을 냉각된 메탄올 20mL로 세척하여 목적 화합물 52.9 g(84.6%)을 수득하였다.The product solution is stirred at 0-5 ° C. for 5 hours to form crystals, and the resulting crystals are filtered off. The filtrate was washed with 20 mL of cooled methanol to give 52.9 g (84.6%) of the title compound.

NMR(CDCl3)δ:5.21(1H), 3.53(2H), 3.68(3H), 2.01(3H), 7.0~7.5(8H)NMR (CDCl 3 ) δ: 5.21 (1H), 3.53 (2H), 3.68 (3H), 2.01 (3H), 7.0 ~ 7.5 (8H)

[비교예 2] Comparative Example 2

메틸 5-(2-브로모-1,1-디메톡시프로필)-2-페닐-티오아세테이트의 제조Preparation of Methyl 5- (2-bromo-1,1-dimethoxypropyl) -2-phenyl-thioacetate

상기 비교예 1로부터 수득한 메틸 5-(2-브로모프로피오닐)-2-페닐-티오페닐아세테이트 화합물 20.0g, 메탄올 110 mL, 트리메틸오르토포르메이트 33mL, 메탄술포닉에시드 0.05 mL를 넣고 18시간동안 환류한다. 20.0 g of methyl 5- (2-bromopropionyl) -2-phenyl-thiophenylacetate compound obtained in Comparative Example 1 was added, 110 mL of methanol, 33 mL of trimethylorthoformate, and 0.05 mL of methanesulphonic acid were added for 18 hours. Reflux for a while.

반응액에 디에틸에테르 200mL를 가한 후 포화 탄산나트륨 150mL로 2회 세척한 후, 유기층에 다시 물 150mL를 가하여 세척하고 포화 식염수 100mL로 세척하고, 혼합물을 무수 황산마그네슘으로 건조, 여과한 후 감압 하에 용매을 제거하여 목적 화합물 17.0g(76.4%)을 얻었다.200 mL of diethyl ether was added to the reaction solution, followed by washing twice with 150 mL of saturated sodium carbonate. Then, 150 mL of water was added to the organic layer, and then washed with 100 mL of saturated brine. The mixture was dried over anhydrous magnesium sulfate, filtered and the solvent was dried under reduced pressure. It removed, and 17.0 g (76.4%) of the target compounds were obtained.

NMR(CDCl3)δ: 4.62(1H), 3.23(6H)NMR (CDCl 3 ) δ: 4.62 (1H), 3.23 (6H)

[비교예 3]Comparative Example 3

메틸 5-(1-에톡시카보닐에틸)-2-페닐-티오아세테이트의 제조Preparation of Methyl 5- (1-ethoxycarbonylethyl) -2-phenyl-thioacetate

상기 비교예 2에서 얻은 할로아세탈 화합물 20g에 톨루엔 40mL, ZnBr2 30mol%(할로아세탈기준)를 가하고 질소 분위기 하에 20시간 동안 환류한다.To 20 g of the halo acetal compound obtained in Comparative Example 2 was added 40 mL of toluene and 30 mol% of ZnBr 2 (based on halo acetal) and refluxed under a nitrogen atmosphere for 20 hours.

반응물을 실온으로 냉각하고 반응물 속에 물 40mL를 가하여 디에틸에테르 150mL로 3회에 걸쳐 추출하고, 추출한 유기층을 정제수 150mL로 세척한 후 무수황산나트륨으로 건조한 후 여과한다. 유기용매을 감압 하에 제거하여 표제화합물 11.1g( 67.2%)을 얻었다.The reaction was cooled to room temperature, 40 mL of water was added to the reaction, followed by extraction three times with 150 mL of diethyl ether. The extracted organic layer was washed with 150 mL of purified water, dried over anhydrous sodium sulfate, and filtered. The organic solvent was removed under reduced pressure to give 11.1 g (67.2%) of the title compound.

실시예 및 비교예에서 알 수 있는 바와 같이 본 발명에 따른 제조방법에 의하면 알파-브롬화반응, 아세탈화 반응, 루이스산에 의한 전위반응으로 이루어진 종래의 제조방법에 비하여 반응시간이 짧고 반응조건이 온화하며, 수율이 높아 생산성에 있어서 매우 유리한 장점이 있음을 알 수 있다.As can be seen from the examples and comparative examples, according to the present invention, the reaction time is shorter and the reaction conditions are milder than those of the conventional production method of alpha-bromination reaction, acetalization reaction, and potential reaction by Lewis acid. And, it can be seen that there is a very advantageous advantage in productivity because the yield is high.

반응조건이 온화하여 부반응이 적어서 수득된 화학식 III 화합물을 분리하지 않고 화학식 1의 디벤조티에핀 화합물을 직접 제조하여도 고리화 반응의 수율이 높을 뿐만 아니라 최종 생성물의 분리가 용이한 장점이 있다.Even if the reaction conditions are mild and the dibenzothiene compound of Formula 1 is prepared directly without separating the obtained compound (III) because of less side reactions, the yield of the cyclization reaction is high and the separation of the final product is easy.

Claims (5)

a) 하기 화학식(II)의 프로피오페논 유도체와 1,2-에탄디올, 1,2-프로판디올, 1,3-프로판디올, 1,2-부탄디올, 1,3-부탄디올, 2,3-부탄디올, 메탄올, 에탄올, n-프로판올, i-프로판올로부터 선택되는 알킬렌디올 또는 모노알코올로로 이루어진 반응 혼합물에 요오드(I2) 촉매와 요오드클로라이드(ICl) 또는 요오드브로마이드(IBr)를 가한 후, 상기 반응 혼합물에 C1-C5알킬 카르복실산의 과산화물, 퍼벤조산, m-클로로퍼벤조산 또는 과산화수소로부터 선택되는 과산화물을 가하여 화학식 III의 디카르복실산 에스테르 화합물을 제조하는 단계;a) propiophenone derivative of formula (II) with 1,2-ethanediol, 1,2-propanediol, 1,3-propanediol, 1,2-butanediol, 1,3-butanediol, 2,3- After adding iodine (I 2 ) catalyst and iodine chloride (ICl) or iodine bromide (IBr) to a reaction mixture consisting of alkylenediol or monoalcohol selected from butanediol, methanol, ethanol, n-propanol and i-propanol, step of the above reaction mixture was added a C 1 -C 5 alkyl peroxide is selected from a carboxylic acid peroxide, perbenzoic acid, m- chloroperbenzoic acid or hydrogen peroxide to dicarboxylic acid ester compound of formula III; b) 화학식 III의 디카르복실산 에스테르 화합물을 산 축합제 존재 하에 화학식 I의 디벤조티에핀 화합물로 변환시키는 단계;b) converting the dicarboxylic acid ester compound of formula III to a dibenzothiefine compound of formula I in the presence of an acid condensing agent; 를 포함하는 것을 특징으로 하는 화학식 I의 디벤조티에핀 화합물을 제조하는 방법.Method for producing a dibenzothione compound of formula (I) comprising a. [상기 화학식에서 R1은 C1-C6의 직쇄 또는 측쇄의 알킬기, 페닐기 또는 벤질기이고, 상기 페닐기와 벤질기에 포함된 페닐기는 C1-C6의 직쇄 또는 측쇄의 알킬, 니트로, 할로겐, 메톡시로 치환될 수 있으며, R2는 C1-C6의 직쇄 또는 측쇄의 알킬기이다.][Wherein R 1 is a C 1 -C 6 linear or branched alkyl, phenyl or benzyl group, and the phenyl group contained in the phenyl group and the benzyl group is C 1 -C 6 linear or branched alkyl, nitro, halogen, May be substituted with methoxy, and R 2 is a C 1 -C 6 straight or branched alkyl group.] 삭제delete 삭제delete 제 1항에 있어서,The method of claim 1, 상기 a) 단계에서 과산화물과 함께 C1-C5알킬 카르복실산의 금속염을 완충용액으로 가하는 것을 특징으로 하는 화학식 I의 디벤조티에핀 화합물을 제조하는 방법.The method of preparing a dibenzothione compound of formula (I), characterized in that the addition of a metal salt of C 1 -C 5 alkyl carboxylic acid with a peroxide as a buffer in step a). 제1항 또는 제4항에 있어서,The method according to claim 1 or 4, 요오드 촉매와 요오드클로라이드(ICl) 또는 요오드브로마이드(IBr)와 과산화물 및 완충용액으로 카르복실산의 금속염을 함께 가하여 반응시키는 것을 특징으로 하는 화학식 I의 디벤조티에핀 화합물을 제조하는 방법.A method for preparing a dibenzothione compound of formula (I), comprising reacting an iodine catalyst with iodine chloride (ICl) or iodine bromide (IBr) with a peroxide and a buffer with a metal salt of carboxylic acid.
KR1020040101502A 2004-12-04 2004-12-04 Process for preparing of dibenzothiepin KR100515922B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020040101502A KR100515922B1 (en) 2004-12-04 2004-12-04 Process for preparing of dibenzothiepin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020040101502A KR100515922B1 (en) 2004-12-04 2004-12-04 Process for preparing of dibenzothiepin

Publications (1)

Publication Number Publication Date
KR100515922B1 true KR100515922B1 (en) 2005-09-20

Family

ID=37304835

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020040101502A KR100515922B1 (en) 2004-12-04 2004-12-04 Process for preparing of dibenzothiepin

Country Status (1)

Country Link
KR (1) KR100515922B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101219504B1 (en) 2005-08-24 2013-01-14 코오롱생명과학 주식회사 The Preparation Method of Dibenzothiepin Derivatives

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101219504B1 (en) 2005-08-24 2013-01-14 코오롱생명과학 주식회사 The Preparation Method of Dibenzothiepin Derivatives

Similar Documents

Publication Publication Date Title
JP5395908B2 (en) Process for producing 4- (1-hydroxy-1-methylethyl) -2-propylimidazole-5-carboxylic acid ester
KR100515922B1 (en) Process for preparing of dibenzothiepin
JP3929545B2 (en) Method for producing 3-acetyl-cyclopentanecarboxylic acid ester
JPS6024781B2 (en) Method for producing cis-2-hydroxy-2-phenyl-r-1-cyclohexanecarboxylic acid
CN114315609A (en) Process for preparing cis-2-aminocyclohexanol
JPS60260555A (en) 2-substituted-5-methylpyridines and synthesis
JP3907787B2 (en) Method for producing benzoic acid derivative
JP2001302658A (en) Method for manufacturing of 3-isochromanones
JPH0223535B2 (en)
KR930010500B1 (en) Process for preparing cotarnine
KR100856133B1 (en) Improved process for preparing atorvastatin
JPH05255271A (en) Production of 3-hydroxymethyl-1-propargylimidazolidine-2,4-dione
KR100699457B1 (en) Process for preparing dibenzothiepin derivatives and intermediates thereof
JP3272340B2 (en) Method for producing 1-[(cyclopent-3-en-1-yl) methyl] -5-ethyl-6- (3,5-dimethylbenzoyl) -2,4-pyrimidinedione
JP4831897B2 (en) Method for producing (2,6-dichloropyridin-4-yl) methanol
BG60580B1 (en) Method for the preparation of 2,2-dimethyl-5-(2,5-dimethylphenoxy)-pentanoic acid, intermediate compounds for its preparation and method for the preparation of the intermediate compounds
KR100952489B1 (en) Cis-2,6-disubstituted tetrahydropyran derivatives and their preparation method
JPS58135843A (en) Intermediate for 4-phenyl-1,3-benzodiazepine and manufacture
KR100769084B1 (en) process for preparing dibenzothiepin derivative
JPH0219831B2 (en)
JPS6133029B2 (en)
JPS59148770A (en) 2,4-dichloro-5-thiazole carboxaldehyde and manufacture
KR900003529B1 (en) Process for preparing 2-acyl-3,4-di'alkoxyanilines
CN116789595A (en) Preparation process of special intermediate of montelukast sodium
CN115710213A (en) Preparation method of cis-chiral 3-fluoro-4-hydroxypiperidine and derivatives thereof

Legal Events

Date Code Title Description
A201 Request for examination
A302 Request for accelerated examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee
R401 Registration of restoration
FPAY Annual fee payment

Payment date: 20120912

Year of fee payment: 8

FPAY Annual fee payment

Payment date: 20130912

Year of fee payment: 9

FPAY Annual fee payment

Payment date: 20140912

Year of fee payment: 10

FPAY Annual fee payment

Payment date: 20150914

Year of fee payment: 11

FPAY Annual fee payment

Payment date: 20160912

Year of fee payment: 12

FPAY Annual fee payment

Payment date: 20170912

Year of fee payment: 13

FPAY Annual fee payment

Payment date: 20180911

Year of fee payment: 14

FPAY Annual fee payment

Payment date: 20190916

Year of fee payment: 15